I Hate Dialysis Message Board
Welcome, Guest. Please login or register.
November 24, 2024, 08:49:05 PM

Login with username, password and session length
Search:     Advanced search
532606 Posts in 33561 Topics by 12678 Members
Latest Member: astrobridge
* Home Help Search Login Register
+  I Hate Dialysis Message Board
|-+  Dialysis Discussion
| |-+  Dialysis: News Articles
| | |-+  FDA Okays Starch-Based Blood Volume Expander
0 Members and 2 Guests are viewing this topic. « previous next »
Pages: [1] Go Down Print
Author Topic: FDA Okays Starch-Based Blood Volume Expander  (Read 1620 times)
okarol
Administrator
Member for Life
*****
Offline Offline

Gender: Female
Posts: 100933


Photo is Jenna - after Disneyland - 1988

WWW
« on: December 28, 2007, 01:31:01 PM »

FDA Okays Starch-Based Blood Volume Expander

By Peggy Peck, Executive Editor, MedPage Today
Published: December 28, 2007
   
ROCKVILLE, Md., Dec. 28 -- Voluven, an intravenous synthetic starch solution, won FDA approval as a blood volume expander for use during and after surgery.

In clinical trials that tested Voluven (6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection) in orthopedic surgery, the product was as safe and effective as Hespan, a starch solution already in use to expand blood volume.

The FDA said that Voluven also demonstrated safety and efficacy when used in newborns and infants undergoing major surgery. In the pediatric studies, the product was compared with an albumin-based blood volume expander.

Moreover, the FDA said, Voluven demonstrated safety in European trials that tested the product in patients ages two to 75.

Blood volume expanders are commonly administered to quickly restore some of the volume lost during surgery so that remaining red blood cells can continue to deliver oxygen to the body's tissues.

Voluven contains a synthetic starch that does not dissolve in water. It is made by linking individual starch molecules and combining them with a salt solution, similar to the salt concentration typically found in blood. Voluven expands the volume of blood plasma and thus draws fluid into capillaries.

The most common side effects from Voluven were nausea and itching.

Voluven is not recommended for patients with known abnormal sensitivity to the synthetic starch used in the product, those experiencing fluid overload, patients on dialysis, and patients with kidney failure not related to low blood volume.

Nor is it recommended for patients with intracranial bleeding or those with severe increases in serum sodium or chloride.

Voluven was not studied in patients with sepsis but the FDA said a post-market clinical trial involving such patients was planned.

Voluven is manufactured by Fresenius Kabi, Bad Homburg, Germany.

http://www.medpagetoday.com/ProductAlert/Prescriptions/tb/7807
Logged


Admin for IHateDialysis 2008 - 2014, retired.
Jenna is our daughter, bad bladder damaged her kidneys.
Was on in-center hemodialysis 2003-2007.
7 yr transplant lost due to rejection.
She did PD Sept. 2013 - July 2017
Found a swap living donor using social media, friends, family.
New kidney in a paired donation swap July 26, 2017.
Her story ---> https://www.facebook.com/WantedKidneyDonor
Please watch her video: http://youtu.be/D9ZuVJ_s80Y
Living Donors Rock! http://www.livingdonorsonline.org -
News video: http://www.youtube.com/watch?v=J-7KvgQDWpU
Pages: [1] Go Up Print 
« previous next »
 

Powered by MySQL Powered by PHP SMF 2.0.17 | SMF © 2019, Simple Machines | Terms and Policies Valid XHTML 1.0! Valid CSS!